PL407413A1 - Zastosowanie pochodnych kwasu aminometylofosfinowego - Google Patents
Zastosowanie pochodnych kwasu aminometylofosfinowegoInfo
- Publication number
- PL407413A1 PL407413A1 PL407413A PL40741314A PL407413A1 PL 407413 A1 PL407413 A1 PL 407413A1 PL 407413 A PL407413 A PL 407413A PL 40741314 A PL40741314 A PL 40741314A PL 407413 A1 PL407413 A1 PL 407413A1
- Authority
- PL
- Poland
- Prior art keywords
- butyl
- heptyl
- pentyl
- hexyl
- propyl
- Prior art date
Links
- OHWRASKXEUIFFB-UHFFFAOYSA-N NCP(O)=O Chemical class NCP(O)=O OHWRASKXEUIFFB-UHFFFAOYSA-N 0.000 title 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 3
- -1 N-methylaminomethyl Chemical group 0.000 abstract 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 abstract 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 2
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000001980 alanyl group Chemical group 0.000 abstract 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 230000003604 ureolytic effect Effects 0.000 abstract 1
- 230000002485 urinary effect Effects 0.000 abstract 1
- 210000001635 urinary tract Anatomy 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Wynalazek dotyczy zastosowanie związków o wzorze ogólnym 1, w którym podstawnikiem R1 jest hydroksyl, hydroksymetyl, aminometyl, N-metyloaminometyl, N,N-dimetyloaminometyl, łańcuch alifatyczny w tym metyl, etyl, propyl, butyl, pentyl, heksyl, heptyl oraz podstawnikami R2, R3 są: łańcuch alifatyczny w tym atom wodoru, metyl, etyl, propyl, butyl, izo-butyl, pentyl, heksyl, heptyl, pierścień alifatyczny w tym cyklopropyl, cyklobutyl, cyklopentyl, cykloheksyl, cykloheptyl, pierścień aromatyczny w tym fenyl, benzyl, 1-fenyloetyl, acylowy w tym acetyl, propionyl, butyryl, benzoyl, aminoacetyl, alanyl jako leków kontroli aktywności ureolitycznej bakterii patogennych kolonizujących układ moczowy oraz zapobiegania wytrącaniu się kamieni w moczu. Ujawniono również zastosowanie związków o wzorze ogólnym 1 jako środków przeciwbakteryjnych w układzie moczowym.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL407413A PL407413A1 (pl) | 2014-03-06 | 2014-03-06 | Zastosowanie pochodnych kwasu aminometylofosfinowego |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL407413A PL407413A1 (pl) | 2014-03-06 | 2014-03-06 | Zastosowanie pochodnych kwasu aminometylofosfinowego |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL407413A1 true PL407413A1 (pl) | 2014-11-24 |
Family
ID=51902584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL407413A PL407413A1 (pl) | 2014-03-06 | 2014-03-06 | Zastosowanie pochodnych kwasu aminometylofosfinowego |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL407413A1 (pl) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104762689A (zh) * | 2015-04-09 | 2015-07-08 | 泰索新材料科技（杭州）有限公司 | 一种阻燃尼龙6纤维及其制备方法 |
-
2014
- 2014-03-06 PL PL407413A patent/PL407413A1/pl unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104762689A (zh) * | 2015-04-09 | 2015-07-08 | 泰索新材料科技（杭州）有限公司 | 一种阻燃尼龙6纤维及其制备方法 |
| CN104762689B (zh) * | 2015-04-09 | 2017-01-04 | 泰索新材料科技（杭州）有限公司 | 一种阻燃尼龙6纤维及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2009000199A1 (en) | Heteromonocyclic compound and use thereof | |
| GEP20217248B (en) | 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh | |
| SA516380328B1 (ar) | مركبات مستبدلة-8،6-دايوكسابيسيكلو[3-2-1]أوكتان-3،2-دايول asgpr كعوامل استهداف | |
| GEP20146125B (en) | Aminopyrimidines as syk inhibitors | |
| PH12016501633A1 (en) | Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors | |
| CR20160523A (es) | Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso para tratar cáncer | |
| BR112013010310A2 (pt) | inibidores de acetil-coa carboxilase de lactama n1/n2 | |
| PH12018500958A1 (en) | Imidazo[4,5-c] quinolin -2-one compounds and their use in treating cancer | |
| CL2009000650A1 (es) | Compuestos derivados de amino-pirazina, inhibidores de cinasa-pi 3; composicion farmaceutica; y uso para el tratamiento de condiciones inflamatorias o alérgicas, tales como enfermedades respiratorias, artritis reumatoide, colitis ulcerativa, entre otras | |
| MX2016012550A (es) | Compuestos biciclicos como inhibidores de produccion de autotaxina (atx) y acido lisofosfatidico (lpa). | |
| GEP20186887B (en) | Bicyclic-fused heteroaryl or aryl compounds and their use as irak4 inhibitors | |
| GEP20207105B (en) | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors | |
| PH12021553233A1 (en) | Imidazopyrimidines as eed inhibitors and the use thereof | |
| GEP20166474B (en) | Pyrazolospiroketone derivatives for use as acetyl-coa carboxylase inhibitors | |
| PH12016501977A1 (en) | 2-AMINO-6-METHYL-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]THIAZIN-8a(8H)-YL-1,3-THIAZOL-4-YL AMIDES | |
| MX2011009847A (es) | Agentes antihelminticos y su uso. | |
| PH12018500957A1 (en) | Imidazo[4,5-c] quinolin -2-one compounds and their use in treating cancer | |
| SG10201900144TA (en) | Pyridone derivative having tetrahydropyranylmethyl group | |
| GEAP201814485A (en) | 2-amino-6-(difluoromethyl)-5, 5-difluoro-6-phenyl-3, 4, 5, 6-tetra- hydropyridines as bace1 inhibitors | |
| MX2011012533A (es) | Espiro-epoxidos como productos intermedios. | |
| PH12018502012B1 (en) | Griseofulvin compound | |
| CU20180139A7 (es) | 5,6,7,8-tetrahidro[1,2,4]triazolo[4,3-a]piridin-3(2h)-onas y 2,5,6,7- tetrahidro-3h-pirrolo[2,1-c][1,2,4]triazol-3-onas sustituidas y procedimientos de preparación | |
| MX378591B (es) | Intermedios para la sintesis de derivados de acido biliar, en particular, de acido obeticolico | |
| NZ746906A (en) | Oxaborole esters and uses thereof | |
| MA32375B1 (fr) | Derives de 5-hydroxymethyl-oxazolidine-2-one pour le traitement de maladies intestinales bacteriennes |